SPRINGFIELD – On February 11, the U.S. Food and Drug Administration issued an emergency use authorization for a new monoclonal antibody, bebtelovimab, for the
MORRIS - An experimental outpatient treatment to treat those infected with COVID-19 is being used at an area hospital. Since last December, Morris Hospital &